Title Image

Publications

ASCO Annual Meeting 2022 Poster Report of Rivoceranib Phase II Study in Recurrent or Metastatic (R/M) Adenoid Cystic Carcinoma (ACC)

Gynecologic Oncology: Phase 3 Publication of Efficacy & Safety Results Comparing Paclitaxel Micellar & Cremophor EL-Paclitaxel

ASCO Annual Meeting 2020 Poster Report of Rivoceranib in Recurrent or Metastatic Adenoid Cystic Carcinoma

ASCO-SITC Clinical Immuno-Oncology Symposium 2019 Poster Report of Rivoceranib in Combination with Nivolumab

AACR 2018 Poster Report of Preclinical Rivoceranib (Apatinib) Combination with Immunotherapy

ACCP 2017 Poster of a Phase 1 Ethnic PK Study

ASCO 2017 Poster Report of Apatinib Phase III Trial in Progress

ESMO 2016 Poster Report of Apatinib Phase II Study Results